113 related articles for article (PubMed ID: 10578253)
21. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice.
Faggioni R; Cattley RC; Guo J; Flores S; Brown H; Qi M; Yin S; Hill D; Scully S; Chen C; Brankow D; Lewis J; Baikalov C; Yamane H; Meng T; Martin F; Hu S; Boone T; Senaldi G
J Immunol; 2001 Nov; 167(10):5913-20. PubMed ID: 11698468
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members.
Dzialo-Hatton R; Milbrandt J; Hockett RD; Weaver CT
J Immunol; 2001 Apr; 166(7):4534-42. PubMed ID: 11254710
[TBL] [Abstract][Full Text] [Related]
23. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity.
Ichikawa K; Yoshida-Kato H; Ohtsuki M; Ohsumi J; Yamaguchi J; Takahashi S; Tani Y; Watanabe M; Shiraishi A; Nishioka K; Yonehara S; Serizawa N
Int Immunol; 2000 Apr; 12(4):555-62. PubMed ID: 10744657
[TBL] [Abstract][Full Text] [Related]
24. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells.
Chow WA; Fang JJ; Yee JK
J Immunol; 2000 Apr; 164(7):3512-8. PubMed ID: 10725705
[TBL] [Abstract][Full Text] [Related]
25. Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats.
Blüher M; Krohn K; Wallaschofski H; Braverman LE; Paschke R
Eur J Endocrinol; 1999 Nov; 141(5):506-11. PubMed ID: 10576768
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
27. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.
Morelli AE; Larregina AT; Smith-Arica J; Dewey RA; Southgate TD; Ambar B; Fontana A; Castro MG; Lowenstein PR
J Gen Virol; 1999 Mar; 80 ( Pt 3)():571-583. PubMed ID: 10091995
[TBL] [Abstract][Full Text] [Related]
28. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
29. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.
Pinkoski MJ; Droin NM; Lin T; Genestier L; Ferguson TA; Green DR
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16174-9. PubMed ID: 12454289
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis.
Hayashi N; Mita E
J Viral Hepat; 1999 Sep; 6(5):357-65. PubMed ID: 10607251
[TBL] [Abstract][Full Text] [Related]
31. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action.
Belanger AJ; Scaria A; Lu H; Sullivan JA; Cheng SH; Gregory RJ; Jiang C
Cardiovasc Res; 2001 Sep; 51(4):749-61. PubMed ID: 11530108
[TBL] [Abstract][Full Text] [Related]
32. The mouse interferon-gamma transgene chronic hepatitis model (Review).
Okamoto T; Yamamura K; Hino O
Int J Mol Med; 1999 May; 3(5):517-20. PubMed ID: 10202184
[TBL] [Abstract][Full Text] [Related]
33. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid.
Li XK; Okuyama T; Tamura A; Enosawa S; Kaneda Y; Takahara S; Funashima N; Yamada M; Amemiya H; Suzuki S
Transplantation; 1998 Dec; 66(11):1416-23. PubMed ID: 9869081
[TBL] [Abstract][Full Text] [Related]
35. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis.
Guillot C; Coathalem H; Chetritt J; David A; Lowenstein P; Gilbert E; Tesson L; van Rooijen N; Cuturi MC; Soulillou JP; Anegon I
J Immunol; 2001 Apr; 166(8):5225-35. PubMed ID: 11290807
[TBL] [Abstract][Full Text] [Related]
36. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
Tagawa Y; Sekikawa K; Iwakura Y
J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
[TBL] [Abstract][Full Text] [Related]
37. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele.
Karray S; Kress C; Cuvellier S; Hue-Beauvais C; Damotte D; Babinet C; Lévi-Strauss M
J Immunol; 2004 Feb; 172(4):2118-25. PubMed ID: 14764677
[TBL] [Abstract][Full Text] [Related]
38. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL.
Peng Y; Gallagher SF; Haines K; Baksh K; Murr MM
J Surg Res; 2006 Jan; 130(1):58-65. PubMed ID: 16154149
[TBL] [Abstract][Full Text] [Related]
40. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
